Further, we predicted the binding sites of CUR and ARHGEF12 by molecular docking, suggesting that CUR may inhibit colon cancer invasion and migration by blocking the ARHGEF12-RhoA complex, which provides a theoretical basis for the molecular mechanism of CUR-mediated inhibition of colon cancer cells. The gene discussed is RHOA; the disease is malignant colon neoplasm.